CyberKnife Stereotactic Ablative Radiotherapy for Recurrent or Oligometastatic Gynecological Cancers

Purpose Use of stereotactic ablative radiotherapy (SABR) in the treatment of recurrent or metastatic lesions from a primary gynecologic cancer is a relatively new concept. The present study aims to assess the safety, efficacy, and possible toxicity profile of CyberKnife SABR, recurrent or metastatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Kataria, Tejinder, Naga, Pushpa, Banerjee, Susovan, Gupta, Deepak, Narang, Kushal, Tayal, Manoj, Bisht, Shyam Singh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical and Scientific Publishers Private Ltd 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460339/
https://www.ncbi.nlm.nih.gov/pubmed/34568224
http://dx.doi.org/10.1055/s-0041-1731576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460339/
https://www.ncbi.nlm.nih.gov/pubmed/34568224
http://dx.doi.org/10.1055/s-0041-1731576

Ejemplares similares